Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Designer probiotics for prevention of enteric infections|
|Citation:||Nature Reviews. Microbiology, 2006; 4(3):193-200|
|Publisher:||Nature Publishing Group|
|Adrienne W. Paton, Renato Morona and James C. Paton|
|Abstract:||Many microbial pathogens, including those responsible for major enteric infections, exploit oligosaccharides that are displayed on the surface of host cells as receptors for toxins and adhesins. Blocking crucial ligand–receptor interactions is therefore a promising therapeutic strategy. One approach is to express molecular mimics of host receptors on the surface of harmless recombinant bacteria that can survive in the gut. These ‘designer probiotics’ bind bacterial toxins in the gut lumen with very high avidity, thereby preventing disease. This article discusses recent progress with this strategy.|
|Keywords:||Animals; Bacteria; Gastroenteritis; Oligosaccharides; Adhesins, Bacterial; Receptors, Cell Surface; Bacterial Toxins; Species Specificity; Molecular Mimicry; Drug Design; Probiotics|
|Description:||© 2007 Nature Publishing Group|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.